The inhibition of cell signaling pathways by antitumor ether lipids

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1390, Issue 1, 1998, Pages 85-102

  Arthur, Gilbert ^a   Bittman, Robert ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; EDELFOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCEROPHOSPHOLIPID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ILMOFOSINE; MILTEFOSINE; PHOSPHOLIPASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SRI 62834; TRANSFERRIN RECEPTOR;

CALCIUM CELL LEVEL; CANCER CELL; CELL PROLIFERATION; CYTOTOXICITY; DRUG MECHANISM; HUMAN; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; FURANS; HUMANS; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; PROTEIN KINASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0032484959     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(97)00163-X     Document Type: Review

References (158)

1. [1] K. Burdzky, P.G. Munder, H.Z. Fischer, O. Westphal, Z. Naturforsch. 19b (1964) 1118-1120.
2. [2] W.E. Berdel, R. Andreesen, P.G. Munder, in: J.F. Kuo (Ed.), Phospholipids and Cellular Regulation, vol. 2, CRC Press, Boca Raton, FL., 1985, pp. 41-73
3. [3] R. Andreesen, Proc. Biochem. Pharmacol. 22 (1988) 118-131.
4. [4] W.E. Berdel, U. Fink, B. Egger, A. Reichert, P.G. Munder, J. Rastetter, J. Natl. Cancer Inst. 66 (1981) 813-817.
5. [5] W.E. Berdel, M. Fromm, U. Fink, W. Pahlke, U. Bicker, A. Reichert, J. Rastetter, Cancer Res. 43 (1983) 5538-5543.
6. [6] D.B.J. Herrmann, H.A. Neumann, Lipids 22 (1987) 955-957.
7. [7] C. Unger, H. Eibl, D.J. Kim, E.A. Fleer, J. Kotting, H.H. Bartsch, G.A. Nagel, K. Pfizenmaier, J. Natl. Cancer Inst. 78 (1987) 219-222.
8. [8] T. Tidwell, G. Guzman, W.R. Vogler, Blood 57 (1981) 794-797.
9. [9] D.R. Huffman, J. Hajdu, F. Snyder, Blood 63 (1984) 545-552.
10. [10] H. Salari, P. Dryden, R. Davenport, S. Howard, K. Jones, R. Bittman, Biochim. Biophys. Acta 1134 (1992) 81-88.
11. [11] W.E. Berdel, E. Greiner, U. Fink, D. Stavron, A. Reichert, J. Rastetter, D.R. Huffman, F. Snyder, Cancer Res. 43 (1983) 541-545.
12. [12] A. Ashagbley, P. Samadder, R. Bittman, R.K. Erukulla, H.-S. Byun, G. Arthur, Anticancer Res. 16 (1996) 1813-1818.
13. [13] W.J. Houlihan, M.L. Lee, P.G. Munder, G.M. Nemecek, D.A. Handley, C.M. Winslow, J. Happy, C. Jaeggi, Lipids 22 (1987) 884-890.
14. [14] E.M. Scholar, Cancer Lett. 33 (1986) 199-204.
15. [15] K. Fujiwara, E.J. Modest, C.E. Welander, C.A. Wallen, Cancer Res. 49 (1989) 6285-6289.
16. [16] X. Lu, G. Arthur, Cancer Res. 52 (1992) 2806-2812.
17. [17] H. Kosano, O. Takatani, Cancer Res. 48 (1988) 6033-6036.
18. [18] M. Modolell, R. Andreesen, W. Pahlke, U. Brugger, P.G. Munder, Cancer Res. 39 (1979) 4681-4686.
19. [19] G.S. Tarnowski, I.M. Mountain, C.C. Stock, P.G. Munder, H.U. Weltzien, O. Westphal, Cancer Res. 38 (1978) 339-344.
20. [20] M. Lohmeyer, R. Bittman, Drugs Future 19 (1994) 1021-1037.
21. [21] W.J. Houlihan, M. Lohmeyer, P. Workman, S.H. Cheon, Med. Res. Rev. 15 (1995) 157-223.
22. [22] H. Brachwitz, C. Vollgraf, Pharmacol. Ther. 66 (1995) 39-82.
23. [23] P. Principe, P. Braquet, Crit. Rev. Oncol. Hematol. 18 (1995) 155-178.
24. [24] E.A.M. Fleer, D. Berkovic, C. Unger, H. Eibl, Prog. Exp. Tumor Res. 34 (1992) 33-46.
25. [25] E.E. Kelley, E.J. Modest, C.P. Burns, Biochem. Pharmacol. 45 (1993) 2435-2439.
26. [26] W.E. Berdel, Br. J. Cancer 64 (1991) 208-211.
27. [27] R. Haase, T. Wieder, C.C. Geilen, W. Reutter, FEBS Lett. 288 (1991) 129-132.
28. [28] C.C. Geilen, T. Wieder, W. Reutter, J. Biol. Chem. 267 (1992) 6719-6724.
29. [29] H. Tronchere, F. Terce, M. Record, G. Ribbes, H. Chap, Biochem. Biophys. Res. Commun. 176 (1991) 157-165.
30. [30] W.R. Vogler, M. Shoji, D.J. Hayzer, Y.P. Xie, M. Renshaw, Leuk. Res. 20 (1996) 947-951.
31. [31] J.D. Watkins, C. Kent, J. Biol. Chem. 268 (1992) 5899-5904.
32. [32] Y. Wang, J.I.S. MacDonald, C. Kent, J. Biol. Chem. 268 (1993) 5512-5518.
33. [33] Y. Wang, T.D. Sweitzer, P.A. Weinhold, C. Kent, J. Biol. Chem. 268 (1993) 5899-5904.
34. [34] F. Mollinedo, C. Gajate, M. Modolell, Biochem. J. 302 (1994) 325-329.
35. [35] A.D. Albani, D.F. Condorelli, G. Mudo, C. Amico, M. Bindoni, N. Belluardo, Neurochem. Int. 22 (1993) 567-574.
36. [36] X. Zhou, G. Arthur, Eur. J. Biochem. 232 (1995) 881-888.
37. [37] D.S. Vallari, M. Record, Z.L. Smith, F. Snyder, Biochim. Biophys. Acta 1006 (1989) 250-254.
38. [38] K. Malarkey, C.M. Belham, A. Paul, A. Graham, A. McLees, P.H. Scott, R. Plevin, Biochem. J. 309 (1995) 361-375.
39. [39] D.T. Denhardt, Biochem. J. 318 (1996) 729-747.
40. [40] N. Divecha, R.F. Irvine, Cell 80 (1995) 269-278.
41. [41] C.-H. Heldin, Cell 80 (1995) 213-223.
42. [42] T. Pawson, Nature 373 (1995) 573-580.
43. [43] C.J. Marshall, Cell 80 (1995) 179-185.
44. [44] C.S. Hill, R. Treisman, Cell 80 (1995) 199-211.
45. [45] J.N. Ihle, Adv. Cancer Res. 68 (1996) 23-65.
46. [46] J. Inglese, W.J. Koch, K. Touhara, R.J. Lefkowitz, Trends Biochem. Sci. 20 (1995) 151-156.
47. [47] T. Hunter, Biochem. Soc. Trans. 24 (1996) 307-327.
48. [48] D.L. Garbers, D.G. Lowe, J. Biol. Chem. 269 (1994) 30741-30744.
49. [49] S.M. Kolodziejczyk, B.K. Hall, Biochem. Cell Biol. 74 (1996) 299-314.
50. [50] T. Taniguchi, Science 268 (1995) 251-255.
51. [51] D-.Y. Noh, S.H. Shin, S.G. Rhee, Biochim. Biophys. Acta 1242 (1995) 99-113.
52. [52] S.E. Egan, B.W. Giddings, M.W. Brooks, L. Buday, A.M. Sizeland, R.A. Weinberg, Nature 363 (1993) 45-51.
53. [53] C.J. Marshall, Nature 383 (1996) 127-128.
54. [54] P. Cohen, Trends Biochem. Sci. 17 (1992) 408-413.
55. [55] H. Kosano, O. Takatani, Cancer Res. 49 (1989) 2868-2870.
56. [56] X. Zhou, X. Lu, C. Richard, W. Xiong, D.W. Litchfield, R. Bittman, G. Arthur, J. Clin. Invest. 98 (1996) 937-944.
57. [57] D.L. Cadena, G.N. Gill, FASEB J. 6 (1992) 2332-2337.
58. [58] M.J. Seewald, R.A. Olsen, I. Sehgal, D.C. Melder, E.J. Modest, G. Powis, Cancer Res. 50 (1990) 4458-4463.
59. [59] R. Huffman, L. Cameron, Anal. Biochem. 203 (1992) 70-75.
60. [60] N.A. Nicola, Annu. Rev. Biochem. 58 (1989) 45-77.
61. [61] M. Shoji, T. Fukuhara, E.F. Winton, W.E. Berdel, W.R. Vogler, Exp. Hematol. 22 (1994) 13-18.
62. [62] H. Kosano, Y. Yasutomo, N. Kugai, N. Nagata, H. Inagaki, S. Tanaka, O. Takatani, Cancer Res. 50 (1990) 3172-3175.
63. [63] H. Kosano, O. Takatani, J. Lipid Mediat. 2 (1990) 117-121.
64. [64] L. Vodlinelich, R. Sutherland, C. Schneider, R. Newman, M. Greaves, Proc. Natl. Acad. Sci. U.S.A. 85 (1983) 835-839.
65. [65] P.J. Casey, A.G. Gilman, J. Biol. Chem. 263 (1988) 2577-2580.
66. [66] M. Liscovitch, L.C. Cantley, Cell 77 (1994) 329-334.
67. [67] M.J. Berridge, Nature 361 (1993) 315-325.
68. [68] S. Cockcroft, G.M.H. Thomas, Biochem. J. 288 (1992) 1-14.
69. [69] S.G. Rhee, K.D. Choi, J. Biol. Chem. 267 (1992) 12393-12396.
70. [70] S.J. Taylor, H.Z. Chae, S.G. Rhee, J.H. Exton, Nature 350 (1991) 516-518.
71. [71] M. Camps, C. Hou, D. Sidiropoulos, J.B. Stock, K.H. Jakobs, P. Gierschik, Eur. J. Biochem. 206 (1992) 821-831.
72. [72] J.L. Blank, K. Shaw, A.H. Ross, J.H. Exton, J. Biol. Chem. 268 (1993) 25184-25191.
73. [73] A. Katz, D. Wu, M.I. Simon, Nature 360 (1992) 686-689.
74. [74] A.V. Smrcka, J.R. Hepler, K.O. Brown, P.C. Sternweis, Science 251 (1991) 804-807.
75. [75] J. Meisenhelder, P.G. Suh, S.G. Rhee, T. Hunter, Cell 57 (1989) 1109-1122.
76. [76] L.C. Cantley, K.R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, S. Soltoff, Cell 64 (1991) 281-302.
77. [77] Y. Banno, Y. Okano, Y. Nozawa, J. Biol. Chem. 269 (1994) 15846-15852.
78. [78] Y. Homma, Y. Emori, EMBO J. 14 (1995) 286-291.
79. [79] G. Powis, M.J. Seewald, C. Gratas, D. Melder, J. Riebow, E.J. Modest, Cancer Res. 52 (1992) 2835-2840.
80. [80] F. Überall, H. Oberhuber, K. Maly, J. Zaknun, L. Demuth, H.H. Grunicke, Cancer Res. 51 (1991) 807-812.
81. [81] T. Pawelczyk, J.M. Lowenstein, Biochem. Pharmacol. 45 (1993) 493-497.
82. [82] N. Liu, K. Fukamai, H. Yu, T. Takenawa, J. Biol. Chem. 271 (1996) 355-360.
83. [83] R. Andreesen, M. Modolell, H.U. Weltzien, H. Eibl, H.H. Common, G.W. Lohr, P.G. Munder, Cancer Res. 38 (1978) 3894-3899.
84. [84] R. Andreesen, M. Modolell, P.G. Munder, Blood 54 (1979) 519-523.
85. [85] I. Junghahn, J. Bergmann, P. Langen, I. Thun, C. Vollgraf, H. Brachwitz, Anticancer Res. 15 (1995) 449-454.
86. [86] D.R. Huffman, V.L. Thomas, F. Snyder, Biochim. Biophys. Acta 1127 (1992) 74-80.
87. [87] M.R. Smith, S.H. Ryu, P.G. Suh, S.G. Rhee, H.F. Kung, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3659-3663.
88. [88] M.R. Smith, Y.L. Liu, H. Kim, S.G. Rhee, H.F. Kung, Science 247 (1990) 1074-1077.
89. [89] A.M. Mohammadi, C.A. Dionne, W. Li, N. Li, T. Spivak, A.M. Honeggar, M. Jaye, J. Schlessinger, Nature 358 (1992) 681-684.
90. [90] B. Margolis, A. Zilberstein, C. Franks, S. Felder, S. Kremer, A. Ullrich, S.G. Rhee, J. Skorecki, J. Schlessinger, Science 248 (1990) 607-610.
91. [91] A. Cuadrado, C.J. Molloy, Mol. Cell. Biol. 10 (1990) 6069-6072.
92. [92] K.G. Peters, J. Marie, E. Wilson, H.E. Ives, J. Escobedo, M. Del Rosario, D. Mirda, L.T. Williams, Nature 358 (1992) 678-681.
93. [93] L. Stephens, Biochem. Soc. Trans. 23 (1995) 207-221.
94. [94] R. Kapeller, L.C. Cantley, Bioessays 16 (1994) 565-576.
95. [95] L. Varticovski, D. Harrison-Findik, M.L. Keeler, M. Susa, Biochim. Biophys. Acta 1226 (1994) 1-11.
96. [96] N.B. Ruderman, R. Kapeller, M.F. White, L.C. Cantley, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1411-1415.
97. [97] B.M. Marte, P. Rodriguez-Viciana, S. Wennstrom, P.H. Warne, J. Downward, Curr. Biol. 7 (1997) 63-70.
98. [98] B.M.T. Burgering, P.J. Coffer, Nature 376 (1995) 599-602.
99. [99] T.F. Franke, S.-I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, P.N. Tsichlis, Cell 81 (1995) 727-736.
100. [100] J. Downward, Nature 376 (1995) 553-554.
101. [101] C.G. Proud, Trends Biol. Sci. 21 (1996) 181-185.
102. [102] M.I. Berggren, A. Gallegos, L.A. Dressler, E.J. Modest, G. Powis, Cancer Res. 53 (1993) 4297-4302.
103. [103] M. Liscovitch, J. Lipid Mediators Cell Signal. 14 (1996) 215-221.
104. [104] C. Gratas, G. Powis, Anticancer Res. 13 (1993) 1239-1244.
105. [105] T. Wieder, Z. Zhang, C.C. Geilen, C.E. Orfaros, A.E. Giuliano, M.C. Cabot, Cancer Lett. 100 (1996) 71-79.
106. [106] S. Orrenius, D.J. McConkey, G. Bellomo, P. Nicotera, Trends Pharmacol. Sci. 10 (1989) 281-285.
107. [107] M.G. Thompson, J.A. Hickman, Biochem. Soc. Trans. 16 (1988) 278.
108. [108] C.M. Lazenby, M.G. Thompson, J.A. Hickman, Cancer Res. 50 (1990) 3327-3330.
109. [109] J. Palmblad, J. Samuelsson, J. Brohult, Scand. J. Clin. Lab. Invest. 50 (1990) 363-370.
110. [110] M. Lohmeyer, P. Workman, Biochem. Pharmacol. 45 (1993) 77-86.
111. [111] J. Bergmann, I. Junghahn, H. Brachwitz, P. Langen, Anticancer Res. 14 (1994) 1549-1556.
112. [112] H. Brinkmeier, M. Schneider, R. Rudel, Cell Calcium 19 (1996) 383-390.
113. [113] Y. Nishizuka, FASEB J. 9 (1995) 484-496.
114. [114] A.C. Newton, J. Biol. Chem. 270 (1995) 28495-28498.
115. [115] K. Buchner, Eur. J. Biochem. 228 (1995) 211-221.
116. [116] O. Sozeri, K. Vollmeyer, M. Liyanage, D. Frith, G. Kour, G.E. Mark III, S. Stabel, Oncogene 7 (1992) 2259-2262.
117. [117] M.P. Carrol, W.S. May, J. Biol. Chem. 269 (1994) 1249-1256.
118. [118] Y. Ueda, S. Hirai, S. Osada, A. Suzuki, K. Mizuno, S. Ohno, J. Biol. Chem. 271 (1996) 23512-23519.
119. [119] W. Kolch, G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marme, U.R. Rapp, Nature 364 (1993) 249-252.
120. [120] H. Cai, U. Smola, V. Wixler, I. Eisenmann-Tappe, T. Diaz-Meco, J. Moscat, U. Rapp, G.M. Cooper, Mol. Cell. Biol. 17 (1997) 732-741.
121. [121] K. Malarkey, C.M. Belham, A. Paul, A. Graham, A. McLees, P.H. Scott, R. Plevin, Biochem. J. 309 (1995) 361-375.
122. [122] T. Van Biesen, B.E. Hawes, J.R. Raymond, L.M. Luttrel, W.J. Koch, R.J. Lefkowitz, J. Biol. Chem. 271 (1996) 1266-1269.
123. [123] H.-C. Liou, D. Baltimore, Curr. Opin. Cell Biol. 5 (1993) 477-487.
124. [124] J. Lozano, E. Berra, M.M. Municio, M.T. Diaz-Meco, I. Domiguez, L. Sanz, J. Moscat, J. Biol. Chem. 269 (1994) 19200-19202.
125. [125] D. Thanos, T. Maniatis, Cell 80 (1995) 529-532.
126. [126] J.H. Exton, Biochim. Biophys. Acta 1212 (1994) 26-42.
127. [127] D.M. Helfman, K.C. Barnes, J.M. Kinkade, W.R. Vogler, M. Shoji, J.F. Kuo, Cancer Res. 43 (1983) 2955-2961.
128. [128] D. Berkovic, E.A. Fleer, H. Eibl, C. Unger, Prog. Exp. Tumor Res. 34 (1992) 59-68.
129. [129] C.C. Geilen, R. Haase, K. Buchner, T. Wieder, F. Hucho, W. Reutter, Eur. J. Cancer 27 (1991) 1650-1653.
130. [130] T.C. Chambers, B. Zheng, J.F. Kuo, Mol. Pharmacol. 41 (1992) 1008-1015.
131. [131] M. Shoji, R. Raynor, W.E. Berdel, W.R. Vogler, J.F. Kuo, Cancer Res. 48 (1988) 6669-6673.
132. [132] P. Berkovic, K. Berkovic, E.A. Fleer, H. Eibl, C. Unger, Eur. J. Cancer 30A (1994) 509-515.
133. [133] B. Zheng, K. Oishi, M. Shoji, H. Eibl, W.E. Berdel, J. Hadju, W.R. Vogler, J.F. Kuo, Cancer Res. 50 (1990) 3025-3031.
134. [134] B.C. Heesbeen, L.F. Verdonck, S.W.G. Hermans, H.G. Van Heugten, G.E.J. Staal, G. Rijksen, FEBS Lett. 290 (1991) 231-234.
135. [135] M. Shoji, R.L. Raynor, E.A.M. Fleer, H. Eibl, W.R. Vogler, J.F. Kuo, Lipids 26 (1991) 145-149.
136. [136] J.A. Sullivan, J.E. Merrit, J.M. Budd, R.F.G. Booth, T.J. Hallam, Eur. J. Immunol. 24 (1994) 621-626.
137. [137] S.E. Wilkinson, T.J. Hallam, Trends Pharmacol. Sci. 15 (1994) 53-57.
138. [138] L.W. Daniel, F. Civoli, M.A. Rogers, P.K. Smitherman, P.A. Raju, M. Roederer, Cancer Res. 55 (1995) 4844-4849.
139. [139] E.C. Heesbeen, L.F. Verdonck, G.E.J. Staal, G. Rijksen, Biochem. Pharmacol. 47 (1994) 1481-1488.
140. [140] I. Trilivas, M. McDonough, J.H. Brown, J. Biol. Chem. 266 (1991) 8431-8438.
141. [141] X. Zhou, G. Arthur, Biochem. J. 324 (1997) 897-902.
142. [142] M.L. Standaert, A. Avignon, K. Yamada, G. Bandyopadhya, R.Y. Farese, Biochem. J. 313 (1996) 1039-1046.
143. [143] J. Parker, L.W. Daniel, M. Waite, J. Biol. Chem. 262 (1987) 5385-5393.
144. [144] Z. Kiss, E. Deli, W.R. Vogler, J.F. Kuo, Biochem. Biophys. Res. Commun. 142 (1987) 661-666.
145. [145] X. Zhou, X. Lu, G. Arthur, Anticancer Res. 12 (1992) 1659-1662.
146. [146] X. Lu, X. Zhou, D. Kardash, G. Arthur, Biochem. Cell Biol. 71 (1993) 122-126.
147. [147] X. Lu, K. Rengan, R. Bittman, G. Arthur, Oncol. Rep. I (1994) 933-936.
148. [148] E. Nishida, Y. Gotoh, Trends Biochem. Sci. 18 (1993) 128-131.
149. [149] K.J. Blumer, G.L. Johnson, Trends Biochem. Sci. 19 (1994) 236-240.
150. [150] M. Lopez-Ilasaca, P. Crespo, P.G. Pellici, J.S. Gutkind, R. Wetzker, Science 275 (1997) 394-397.
151. [151] S. Ghosh, J.C. Strum, V.A. Sciorra, L. Daniel, R.M. Bell, J. Biol. Chem. 271 (1996) 8472-8480.
152. [152] H. Cai, P. Erhardt, M.T. Troppmair, M.T. Diaz-Meco, G. Sithananandam, U.R. Rapp, J. Moscat, G.M. Cooper, Mol. Cell. Biol. 13 (1993) 7645-7651.
153. [153] A. Huwiler, J. Brunner, R. Hummel, M. Vervoordeldonk, S. Stabel, H. Van den Bosch, J. Pfeishifter, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6959-6963.
154. [154] P. Principe, C. Sidoti, H. Coulomb, C. Brouquet, P. Braquet, Cancer Detec. Prev. 18 (1994) 393-400.
155. [155] A.D. Laird, S.J. Taylor, M. Oberst, D. Shalloway, J. Biol. Chem. 270 (1995) 26742-26745.
156. [156] H. Tamemoto, T. Kadowaki, K. Tobe, K. Ueki, T. Izumi, Y. Chatani, M. Kohno, M. Kasuga, Y. Yazaki, Y. Akanuma, J. Biol. Chem. 267 (1992) 20293-20297.
157. [157] J. Hofmann, P.M. O'Connor, J. Jackman, C. Schubert, F. Ueberall, K.W. Kohn, H. Grunicke, Biochem. Biophys. Res. Commun. 199 (1994) 937-943.
158. [158] G. Powis, Pharmacol. Ther. 62 (1994) 57-95.